Yonghe Medical Group Co., Ltd. (HKG:2279)
Hong Kong · Delayed Price · Currency is HKD 1.970
-0.020 (-1.01%)
At close: Feb 13, 2026
Yonghe Medical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,766 | 1,804 | 1,777 | 1,413 | 2,169 | 1,638 | |
Revenue Growth (YoY) | -4.53% | 1.53% | 25.80% | -34.85% | 32.37% | 33.80% |
Cost of Revenue | 660.75 | 720.29 | 780.07 | 540.21 | 588.6 | 416.67 |
Gross Profit | 1,105 | 1,084 | 997.19 | 872.58 | 1,580 | 1,222 |
Selling, General & Admin | 1,078 | 1,188 | 1,419 | 1,024 | 1,320 | 941.63 |
Research & Development | 17.88 | 21.25 | 29.28 | 18.5 | 14.16 | 11.82 |
Other Operating Expenses | -1.81 | -2.74 | 6.68 | -8.66 | -4.92 | -2.55 |
Operating Expenses | 1,094 | 1,206 | 1,455 | 1,034 | 1,329 | 950.95 |
Operating Income | 11.44 | -121.95 | -457.47 | -161.46 | 250.49 | 270.68 |
Interest Expense | -32.33 | -41.22 | -54.16 | -51.23 | -51.95 | -36.29 |
Interest & Investment Income | 10.98 | 10.57 | 12.7 | 15.26 | 6.13 | 0.94 |
Currency Exchange Gain (Loss) | -0.08 | 0.05 | -12.01 | 88.12 | - | - |
Other Non Operating Income (Expenses) | -1.71 | -0.03 | 0.02 | -0.25 | 0.21 | -0.44 |
EBT Excluding Unusual Items | -11.71 | -152.58 | -510.92 | -109.55 | 204.88 | 234.9 |
Gain (Loss) on Sale of Assets | -22.5 | -51.78 | -52.35 | -2.04 | -1.13 | -3.98 |
Asset Writedown | -46.42 | -60.48 | -28.4 | - | - | - |
Other Unusual Items | 9.85 | 9.55 | 6.45 | 2.12 | 6.52 | - |
Pretax Income | -70.78 | -255.29 | -585.22 | -109.47 | 210.28 | 230.91 |
Income Tax Expense | -10.72 | -28.72 | -38.54 | -23.61 | 90.09 | 67.58 |
Earnings From Continuing Operations | -60.07 | -226.57 | -546.68 | -85.86 | 120.19 | 163.33 |
Minority Interest in Earnings | 0.21 | 0.23 | 0.29 | - | - | - |
Net Income | -59.86 | -226.34 | -546.39 | -85.86 | 120.19 | 163.33 |
Preferred Dividends & Other Adjustments | - | - | - | -1.88 | 2.62 | 16.37 |
Net Income to Common | -59.86 | -226.34 | -546.39 | -83.98 | 117.57 | 146.96 |
Net Income Growth | - | - | - | - | -26.41% | 358.49% |
Shares Outstanding (Basic) | 503 | 501 | 506 | 513 | 401 | 376 |
Shares Outstanding (Diluted) | 503 | 501 | 506 | 513 | 430 | 419 |
Shares Change (YoY) | 0.21% | -1.01% | -1.36% | 19.23% | 2.65% | 4.77% |
EPS (Basic) | -0.12 | -0.45 | -1.08 | -0.16 | 0.29 | 0.39 |
EPS (Diluted) | -0.12 | -0.45 | -1.08 | -0.16 | 0.28 | 0.39 |
EPS Growth | - | - | - | - | -28.32% | 337.63% |
Free Cash Flow | 323.72 | 182.95 | -176.35 | -349.14 | 255.65 | 359.37 |
Free Cash Flow Per Share | 0.64 | 0.36 | -0.35 | -0.68 | 0.59 | 0.86 |
Dividend Per Share | - | - | - | - | 0.076 | - |
Gross Margin | 62.58% | 60.08% | 56.11% | 61.76% | 72.86% | 74.57% |
Operating Margin | 0.65% | -6.76% | -25.74% | -11.43% | 11.55% | 16.52% |
Profit Margin | -3.39% | -12.54% | -30.74% | -5.94% | 5.42% | 8.97% |
Free Cash Flow Margin | 18.33% | 10.14% | -9.92% | -24.71% | 11.79% | 21.93% |
EBITDA | 144.42 | 35.84 | -292.24 | -54.42 | 342.56 | 346.41 |
EBITDA Margin | 8.18% | 1.99% | -16.44% | -3.85% | 15.80% | 21.14% |
D&A For EBITDA | 132.98 | 157.79 | 165.23 | 107.04 | 92.07 | 75.73 |
EBIT | 11.44 | -121.95 | -457.47 | -161.46 | 250.49 | 270.68 |
EBIT Margin | 0.65% | -6.76% | -25.74% | -11.43% | 11.55% | 16.52% |
Effective Tax Rate | - | - | - | - | 42.84% | 29.27% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.